Sarker Mridul

Title: Sarker Mridul: Innovator in Protein Nanocages

Introduction

Sarker Mridul is a notable inventor based in Singapore, SG. He has made significant contributions to the field of biomedical engineering, particularly in the development of innovative therapeutic solutions. With a focus on melanocyte-targeting technologies, Mridul has been awarded 2 patents for his groundbreaking work.

Latest Patents

One of Mridul's latest patents is titled "Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages." This invention relates to protein nanocages that comprise a melanocyte-targeting moiety and pharmaceutical compositions that utilize these protein cages. The methods developed aim to treat or diagnose hyperpigmentation disorders and other melanocyte-related conditions. In the preferred embodiment, the protein nanocage is composed of the E2 protein of the pyruvate dehydrogenase multi-enzyme complex, featuring a skin-penetrating and cell-permeating SPACE moiety, along with a melanocyte-targeting moiety derived from alpha melanocyte-stimulating hormone.

Career Highlights

Throughout his career, Sarker Mridul has worked with esteemed institutions such as Nanyang Technological University and the National Skin Center. His work has been pivotal in advancing the understanding and treatment of skin-related disorders.

Collaborations

Mridul has collaborated with notable colleagues, including Sierin Lim and Sathyamoorthy Bhaskar. These partnerships have further enriched his research and innovation efforts.

Conclusion

Sarker Mridul's contributions to the field of protein nanocages and melanocyte-targeting therapies highlight his role as a leading inventor in biomedical engineering. His innovative patents and collaborations continue to pave the way for advancements in therapeutic solutions.